Former Chinese Nationalist Party (KMT) vice chairman Hau Lung-bin (郝龍斌) is to appeal the Food and Drug Administration’s (FDA) authorization of Medigen Vaccine Biologics’ COVID-19 vaccine, he said yesterday.
The administration on July 19 granted Medigen emergency use authorization, even though the drugmaker had not yet completed phase 3 clinical trials.
The government should not authorize the use of a vaccine that has not completed phase 3 trials, Hau said in Taipei on the sidelines of an event to distribute boxed meals with former president Ma Ying-jeou (馬英九) and Broadcasting Corp of China chairman Jaw Shaw-kong (趙少康).
Photo: Fang Pin-chao, Taipei Times
Hau said the government had politicized science in its hasty approval of a domestically developed COVID-19 vaccine.
The emergency use authorization of a vaccine prior to the completion of phase 3 trials is unprecedented, as it means a vaccine’s efficacy has not been verified, he said, adding that President Tsai Ing-wen (蔡英文) and Vice President William Lai (賴清德) have set a poor example in saying they would take the Medigen vaccine.
“The government should spare the lives of the Taiwanese people,” he said.
Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the Central Epidemic Command Center, yesterday said that the center respects the right of citizens to file petitions related to the authorization.
Medigen is the only Taiwanese company to which the FDA has granted emergency use authorization.
The administration said it based its decision on data Medigen obtained in a phase 2 clinical trial of about 4,000 participants earlier this year, which was analyzed through immunobridging and compared with a control group of 200 recipients of the AstraZeneca COVID-19 vaccine in Taoyuan.
Immunobridging is a method to infer the efficacy of a vaccine by comparing the concentration of neutralizing antibodies in each group of recipients with that of an approved vaccine.
Medigen on July 20 announced that it had received permission to conduct a 1,000-person phase 3 clinical trial in Paraguay for its COVID-19 vaccine.
Participants in the trial, to be held with the National University of Asuncion’s medical school, would be recruited in the third quarter of this year and Medigen expects to have interim analysis data in the fourth quarter, the company said.
The trial would compare recipients of the Medigen and AstraZeneca vaccines through immunobridging, it said.
Medigen did not elaborate on its reasons for holding such a small trial or its use of immunobridging, which has been criticized as an insufficient substitute for traditional efficacy data.
Taiwan has agreed to buy 10 million doses of COVID-19 vaccines from two Taiwanese manufacturers: Medigen and United Biomedical, which has not yet been granted emergency use authorization by the FDA.
The Coast Guard Administration (CGA) and Chunghwa Telecom yesterday confirmed that an international undersea cable near Keelung Harbor had been cut by a Chinese ship, the Shunxin-39, a freighter registered in Cameroon. Chunghwa Telecom said the cable had its own backup equipment, and the incident would not affect telecommunications within Taiwan. The CGA said it dispatched a ship under its first fleet after receiving word of the incident and located the Shunxin-39 7 nautical miles (13km) north of Yehliu (野柳) at about 4:40pm on Friday. The CGA demanded that the Shunxin-39 return to seas closer to Keelung Harbor for investigation over the
An apartment building in New Taipei City’s Sanchong District (三重) collapsed last night after a nearby construction project earlier in the day allegedly caused it to tilt. Shortly after work began at 9am on an ongoing excavation of a construction site on Liuzhang Street (六張街), two neighboring apartment buildings tilted and cracked, leading to exterior tiles peeling off, city officials said. The fire department then dispatched personnel to help evacuate 22 residents from nine households. After the incident, the city government first filled the building at No. 190, which appeared to be more badly affected, with water to stabilize the
DEEPER REVIEW: After receiving 19 hospital reports of suspected food poisoning, the Taipei Department of Health applied for an epidemiological investigation A buffet restaurant in Taipei’s Xinyi District (信義) is to be fined NT$3 million (US$91,233) after it remained opened despite an order to suspend operations following reports that 32 people had been treated for suspected food poisoning, the Taipei Department of Health said yesterday. The health department said it on Tuesday received reports from hospitals of people who had suspected food poisoning symptoms, including nausea, vomiting, stomach pain and diarrhea, after they ate at an INPARADISE (饗饗) branch in Breeze Xinyi on Sunday and Monday. As more than six people who ate at the restaurant sought medical treatment, the department ordered the
Taiwan plans to cull as many as 120,000 invasive green iguanas this year to curb the species’ impact on local farmers, the Ministry of Agriculture said. Chiu Kuo-hao (邱國皓), a section chief in the ministry’s Forestry and Nature Conservation Agency, on Sunday said that green iguanas have been recorded across southern Taiwan and as far north as Taichung. Although there is no reliable data on the species’ total population in the country, it has been estimated to be about 200,000, he said. Chiu said about 70,000 iguanas were culled last year, including about 45,000 in Pingtung County, 12,000 in Tainan, 9,900 in
RSS